http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2180824-C2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72e2a023c558b51d973e979033b70490
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_716283b4d47c7564eba0b73a2e3c1704
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
filingDate 1999-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2002-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fccc0156771478a0531aabab4e9e0925
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_959225d0cca867b1f212882ee131b304
publicationDate 2002-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2180824-C2
titleOfInvention Method for stretching tissues in periorbital zone
abstract FIELD: medicine. SUBSTANCE: method involves creating two subcutaneous cavities at the defect localization place in and in adjacent zone to implant two-ballooned latex expander unit having basic and auxiliary balloon. physiological salt solution is introduced into the auxiliary balloon in postoperative period. The basic balloon is expanded to reach required tension intensity in the zone above the balloon. The basic balloon is used so that its volume is equal to precalculated one to enable required tissue tension to be achieved, and its wall thickness is equal to 0.1-0.2 mm. The balloon is squeezed before being introduced. The basic balloon volume is increased by expanding. EFFECT: enhanced effectiveness of treatment. 2 dwg
priorityDate 1999-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5234
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448670727

Total number of triples: 15.